Accelerated Ventures invests £3.5m in Biosignatures
London-based Accelerated Ventures has invested £3.5m in Newcastle-headquartered biotechnology startup Biosignatures.
More on Expansion
Palatine-backed CET bolts on Esseltest
Palatine has backed two bolt-ons for infrastructure and property assurance services provider CET UK
PeakSpan leads $6m series-C extension for JRNI
Latest funding round also saw participation from Downing Ventures and Somerston Group
Morpheus et al. invest $40m in Starship series-A
Shasta, Matrix TDK and MetaPlanet also invested in the autonomous delivery company
Nordwind's B2B Media Group bolts on Aumago
Nordwind Capital's portfolio company B2B Media Group has acquired a digital marketing agency
Latest News
Star Capital invests in Windhoist
Windhoist Holdings is Star Capital's sixth acquisition from its Strategic Assets III vehicle
Palatine launches £300m fourth-generation vehicle
Both Palatine Private Equity Fund III and IV used Evercore as their placement agent
DBAG buys Cartonplast from Stirling Square
GP deploys capital from its DBAG Fund VII, which held a final close on its €1bn hard-cap in 2016
Pemberton closes second direct lending fund on €3.2bn
Pemberton's most recent fundraise brings the direct lender's assets under management to €5.5bn